Raymond James Trust N.A. Repligen Corp Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Repligen Corp stock. As of the latest transaction made, Raymond James Trust N.A. holds 2,750 shares of RGEN stock, worth $408,375. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,750
Previous 2,275
20.88%
Holding current value
$408,375
Previous $286,000
43.01%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$949 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$749 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$241 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$211 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.24B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....